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Abstract
Aim: To discuss the information contrast sensitivity
(CS) testing can provide over visual acuity testing,
and review the literature relating to CS deficits in
children to determine whether there is an optimum
test available.
Methods: A literature search of databases available
through the University of Liverpool library was
performed. All searches related to the importance
of CS in children, paediatric conditions affecting CS
and current clinical tests available for the assessment
of CS.
Results:Many paediatric conditions exist where CS is
defective, often despite ‘normal’ visual acuity (VA):
for example, optic pathway gliomas, myopia and
primary congenital glaucoma. The finding of a loss of
CS has been found to be more prominent and
disturbing to an individual than a loss of VA,
emphasising the importance of CS assessments in
children. Therefore, the clinical assessment of CS in
children is valuable in terms of strategies to support
the child and establishing the individual’s functional
level of vision. Unfortunately, current paediatric
clinical tests of CS have failed to demonstrate the
same standards and repeatability and reliability as
adult tests for the assessment of CS.
Conclusions: The range of functional deficits that
accompany paediatric ocular disease require more
assessments for full evaluation of visual function than
standard VA tests. However, reliable assessments for
paediatric CS are limited. A new paediatric CS test
may be of clinical value.
Key words: Contrast sensitivity, Paediatric, Visual
impairment
Introduction
The ability to test visual acuity (VA) is of great clinical
value, and affects diagnostic and management decisions.
However, measuring an individual’s ability to detect
minor changes in luminance is also of importance and is
often referred to as contrast sensitivity (CS). Today in
clinical practice often only VA is assessed, by means of
an optotype chart in Snellen or logMAR format in high
contrast. Although VA measurements are essential in
determining whether a patient is suffering from a visual
disturbance, patients can often experience visual dis-
turbances in the presence of normal VA.
The aims of this review are to discuss the information
CS testing can provide over visual acuity testing, and to
review the literature relating to CS deficits in children to
determine whether there is an optimum test available. To
achieve these aims we will evaluate available evidence
relating to CS testing in children. The following points
will be addressed:
. the limitations of the assessment of VA in isolation;
. the role of the assessment of CS;
. normal development and paediatric conditions
affecting CS;
. clinical assessments of CS.
The search of the literature utilised the following
databases available through the University of Liverpool
library: Medline, Scopus, Web of knowledge, and the
Cochrane library. Key words searched for included:
paediatric, visual impairment, contrast sensitivity,
clinical tests, functional vision, and visual acuity.
Boolean logic enabled an effective search strategy to
be employed.1
Limitations of visual acuity testing
VA is a measure of spatial vision which is defined as the
finest element that can be resolved at a fixed distance2–4
and is the most frequently used indicator of spatial vision
in both clinical studies and clinical practice.3 The
measurement of VA in children is often utilised to
detect refractive errors, amblyopia and other ocular
anomalies as well as to monitor improvement of vision
with ongoing treatments.4 While there are a wide range
of VA tests available, ensuring that it can be assessed in
all patients irrespective of cognitive ability, VA only
measures an individual’s recognition of the smallest
high-contrast pattern visible.5,6 Although the measure of
VA provides important clinical information, the ability
to measure CS in a clinical environment is also of
importance in all ages and is a highly recommended as
part of a functional visual assessment.2–3,7 Studies have
demonstrated high levels of correlation between VA and
other spatial vision measures such as CS, but there is
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considerable variation, with the correlation being as low
as 0.27 in low vision patients, and up to 0.79 in patients
with normal VA.3,8,9 The variability in the correlation
emphasises the limitations of VA results. Such a large
variability is in part attributable to differences in the
population characteristics between studies, but it is also
known that factors such as the method of assessment of
CS, the luminance and data collection differences all
contribute to variation in both VA and CS.9,10 None-
theless, there is also a possibility that participant(s) may
have been suffering from a condition in which a normal
level of VA is demonstrable despite a sensory visual
impairment causing a reduced CS threshold.
Functional importance of the assessment of contrast
sensitivity
CS is a measure of the ability to detect slight changes in
luminance; it can provide an evaluation of the detection
of objects of varying spatial frequencies and/or variable
contrast.11 The contrast threshold is the reciprocal of CS,
and defined as the level of contrast at which a light and
dark pattern is first discriminated. The measurement of
contrast thresholds for sine-wave gratings across a range
of spatial frequencies determines an individual’s contrast
sensitivity function (CSF).11 While the assessment of the
complete CSF provides a detailed evaluation of an
individual’s CS, it is the contrast threshold at one
specific spatial frequency which is more commonly
assessed during a clinical assessment, primarily due to
time constraints. For example, using the Pelli-Robson
test assesses individuals contrast thresholds at a specific
spatial frequency at the recommended testing distance of
1 metre.9
The assessment of CS increases our understanding of
how individuals perceive the world, as it provides a more
complete and detailed assessment of visual function
related to a ‘real visual environment’.12 The measure-
ment of CS has been shown to contribute additional
information to that provided by VA alone, becoming the
most comprehensive single means of evaluating the
visual system’s response to pattern information, parti-
cularly in patients with visual impairments.2,3,5,13,14 CS
plays an important role in mobility performance, the
ability to recognise faces and the ability to undertake
daily living tasks in individuals with visual impair-
ments.9 The ability of an adult patient with a severe
vision impairment to resolve details in daily living, such
as reading, is assessed by measures of VA, whereas the
ability of a person to detect objects relative to their
background, for example when walking down the stairs,
is measured by CS.15 There was no evidence found in the
literature suggesting that this does not apply to a child’s
visual system. Evaluating remaining functional vision
such as CS and VA in both children and adults with
severe vision loss is key when determining rehabilitative
strategies and quality of life. Overall, studies have shown
that the assessment of other spatial vision measures
contributes additional information to that provided by
acuity alone.2–3,5,12–14
Paediatric disease and conditions with defective
contrast sensitivity
Numerous conditions can occur in children which
ultimately affect the individual’s functional vision (a
wide range of examples are included in Table 1).
Assessing CS and finding a defective contrast threshold
in many of these patients could provide an explanation
as to why children may be demonstrating behaviour
compatible with a sensory visual impairment despite
normal VA.16 Assessing CS in a clinical setting may also
prevent patients with a visual function disorder that is
not apparent on standard VA testing from being con-
sidered as having ‘normal vision’ and being discharged.
Table 1 clearly demonstrates that children with
disabilities are likely to have visual disorders with an
increased risk of reduced visual function, including
reduced CS.6,13,17–28 The correlation between the
individual’s VA and CS can be variable, and therefore
a quick, reliable and repeatable assessment of both CS
and VA is desirable, particularly for children with or
without disabilities.3,8,9 Good et al. and Fazzi et al.
demonstrated that over 60% of children with cerebral
palsy have cerebral visual impairment, resulting in a
substantial loss of CS (see Table 1).25,29 In addition,
children with Down syndrome are at risk of a variety of
ocular anomalies such as cataracts, high refractive errors,
strabismus and congenital glaucoma, which can all have
an adverse effect on CS.14 In these children it is vital to
be able to establish their functional level of vision, i.e.
their CS threshold, to acknowledge what treatment or
support may be required to ensure the child has the best
possible outcome.
Studies have demonstrated a reduction of CS in
patients with developmental delay (10.5%).30,31 These
children are also more likely to suffer from strabismus
and refractive errors such as hyperopia, astigmatism and
anisometropia, all which can affect an individual’s CS
threshold.30,31 Therefore, a reduced CS threshold in
patients with Down syndrome or developmental delay
may not be directly attributable to the primary disorder,
but possibly due to the associated ocular abnormalities
that are prominent in these patients. Although this has
been supported in the literature, it is not apparent that the
individual associated ocular abnormalities have been
specifically examined, but rather the effect of the overall
disability on CS.30,31
The growing population of children born prematurely
is also known to have a high prevalence of ophthalmo-
logical and neuro-developmental disorders in which the
retina or posterior visual pathways may be disturbed,
thus affecting CS.32,33 Previous studies have shown
prematurely born children had statistically significant
lower CS at all spatial frequencies when compared with
full-term children. Although results were of statistical
significance, mean differences in logarithmic CS (Log
CS) were only slight: for example, a mean difference of
0.03 Log CS (1.5 cpd) and 0.09 Log CS (3 cpd) were
shown.32 One may suggest that the reduced CS in these
children is not directly attributable to the prematurity but
the associated ophthalmological and neuro-developmen-
tal disorders that occur as a result of the prematurity. In
support of this, Larsson et al. found premature children
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without associated neurological conditions still demon-
strated reduced CS compared with full-term children.32
It is the loss of CS that can be more disturbing, and the
CS that is more severely reduced, as premature children
can demonstrate normal levels of VA with defective
CS.2,15,32 Although children with poor VA were
excluded from Larsson et al. study, premature children
had significantly lower CS in the mid to low range of
spatial frequencies, highlighting visual problems despite
normal VA.32
CS measurements can monitor or influence treatment
plans in conditions such as retinitis pigmentosa or
amblyopia. In retinitis pigmentosa the assessment of CS
can reveal subtle improvements in patients undergoing
new drug treatment and therefore necessitating detailed
evaluation, as high-contrast figures are insufficient to
evaluate mild damage to foveal cones.21,34 Additionally,
CS measurements can contribute to the treatment plans
of other conditions such as amblyopia. Both CS and VA
are reduced in the amblyopic eye in amblyopia patients
and should both be measured to monitor functional
vision in the amblyopic eye during occlusion treatment.
However, CS in the non-amblyopic eye in these patients
should also be monitored as studies have shown that
despite normal VA the eye which is considered ‘normal’
does actually demonstrate a defective CS threshold.28
In addition to influencing management, CS may aid in
the diagnosis of some conditions. During the early stages
of optic neuritis VA can remain at a normal level whilst
low- and mid-range spatial frequencies of CS are
reduced.22,35 CS measures often provide the initial
indications of visual compromise, even prior to changes
in the fundus appearance.17 In young children infectious
and post-infectious causes of optic nerve impairment
should be considered as alternatives to optic neuritis.
Therefore, early recognition of symptoms is important,
which could be detected through CS testing.35 Addition-
ally, the assessment of CS in some cases can provide a
much quicker diagnosis than currently used tests. For
example, the current standard assessments to accurately
diagnose optic pathway gliomas (OPGs) are often
lengthy and require young children to be co-operative,
or are extremely expensive and involve additional risks
(e.g. neuro-imaging). Standard VA assessments are not
reliable enough as they can fail to detect optic nerve
compression.22,35 However, sweep visual evoked poten-
tials (sVEPs) have been suggested as an effective
screening test to assess an individual’s functional vision,
using grating and CS stimuli.24 These findings suggest
that a repeatable, reliable, quicker and more cost-
effective method of assessing CS in children would be
valuable to use in a clinical setting to aid in the diagnosis
of OPGs.
Visual function, including CS, in children with neuro-
logical impairments can often be difficult to quantify.
Studies have proven that a visual skills inventory
completed by parents or a structured history taken by a
clinician is often useful in determining whether a child is
likely to have reduced visual function.36 Although the
assessment of CS is desirable, it is not always realistic or
Table 1. Paediatric conditions and their effect on VA and CS6,17–28
Condition n Effect on VA Effect on CS
Myopia17 105 myopic eyes
28 control eyes
Corrected acuities 6/6 Snellen or better Loss at higher spatial frequencies for






Grating acuity reduced on average by 0.6
log units
100% had losses in spatial CS in deprived







(PERG) deficits in PCG patients. PERG
almost reached level of controls at high
temporal frequency
In both groups, mean CS peaked at 6 cpd,
but significantly lower in patients with PCG
at all spatial frequencies
Retinopathy of
prematurity (ROP)20
291, severe threshold ROP in
1/both eyes + cryotherapy
10 low birth weight controls
(ÿROP)
63% showed VA and CS correlated well
post-treatment. 30.4% had better CS than
VA





Mean age 37.8 Ô 17.6 years
VA varies in RP patients due to the
stages of disease. CS and VA
significantly correlated when VA >20/50
CS values 15–170 at 12 cpd in patients with
VA better than 20/25. Reduced CS found at
both high and low spatial frequencies
Optic neuritis22 30 Statistically significant difference
between VA of the affected and
unaffected eyes
CS showed the most significant difference
between the affected and unaffected eyes
Septo-optic dysplasia
(SOD)23
17 VA significantly decreased in all
children, 7 had perception of light only





Corrected VA of 6/9 or better Significant reduction in CS in OPG patients
who had normal VA
Cerebral visual
impairment (CVI)25
34 months to 5 years
16 controls
Grating acuity thresholds decreased by a
factor of 2.3 compared with controls
(median acuity: 0.49 logMAR)




84 infants Mildly reduced VA early on, gradual
maturation with age paralleling a normal
VA curve
Significantly reduced at all spatial
frequencies
Amblyopia6,28 22 aged 3–6 years VA varied and depended on severity of
amblyopia
Reduced at high spatial frequencies and other
areas of CSF. Non-amblyopic eye showed
reduced CS threshold despite a ‘normal’ VA
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possible to routinely assess it in all patients. Using the
visual skills inventory has been proven to be a good way
of identifying potential CS deficits necessitating further
visual function assessments such as CS.36
Development of contrast sensitivity
In visually normal children CS develops rapidly over the
first 6 months of life. There is rapid neural development
of the visual system as a whole over the first 3 months of
life with CS reaching adult levels for at least low spatial
frequencies by 3 months old.37,38 Norcia et al. stated that
between 4 and 9 weeks CS improves significantly at all
spatial frequencies. However, after 9 weeks of age
maximum CS thresholds increase by a smaller amount
while sensitivity at higher spatial frequencies continues
to increase dramatically.39
The time during which neural plasticity makes the
visual system vulnerable to abnormal experiences and
interruptions in normal visual development is defined as
the sensitive period.39 For VA, the sensitive period
extends to approximately 8 years of age, but the sensitive
period for CS has not been clearly defined. The CSF is
known to continue to develop beyond the age of 8 years,
not reaching a maximum until approximately 20 years of
age, suggesting that the sensitive period for CS may
extend beyond the age of 8 years.11,31,38–41 Leat and
Wegmann supported this evidence by demonstrating a
statistically significant difference in CS thresholds
between two age groups: 6 to <8 years and 23 to 37
years ( p< 0.001) (data in Table 2).13 Therefore, it is
important to compare CS values with appropriate age-
related norms, due to the variability of CS with age (see
Table 2). For example, mean CS thresholds in children
aged between 6 and 12 years old have been found with
the Pelli-Robson CS chart to be between 1.63/1.65 Log
CS (SD: 0.12/0.06 Log CS) and 1.72/1.76 Log CS (SD:
0.08/0.07 Log CS) for the right and left eye, respec-
tively.13,42 The significant variation between mean
thresholds may be due to the development of CS
thresholds/function, age variations, the scoring methods
used and the luminance used during assessment.11
Mean CS thresholds for adults between the ages of 20
and 40 years have shown to be 1.84 Ô 0.12 Log CS.
Over the age of 60 years mean CS thresholds decrease
significantly to around 1.72 Ô 0.08 Log CS.42 However,
regardless of the variation in scores across the different
age categories, studies have stated a Pelli-Robson score
of at least 1.05 Log CS is required for fluent reading.13,43
Indicating a score below 1.05 Log CS with the Pelli-
Robson chart could identify a visual impairment which
may have an impact on an individual’s daily routine.
Contrast sensitivity tests
Clinical assessment of CS involves the use of either sine/
square-wave gratings or optotype charts. The Pelli-
Robson CS letter chart is one of the most readily
available methods for assessing CS thresholds in adult
patients (Fig. 1). The Pelli-Robson is an optotype CS
chart of a fixed spatial frequency and reducing contrast.
CS charts using optotypes adopt a specific psycho-
physical method of identification. In the case of the
Pelli-Robson, it has a 26-alternative forced-choice
design (the subject is ‘forced’ to give a response at
threshold rather than just indicating the letter cannot be
seen), ensuring a more accurate threshold is reached. The
test uses 10 Sloan letters which are comparable to the
Landolt C. Each letter has a recognition score to ensure
each triplet is of the same difficulty in terms of recog-
nition. Forced-choice procedures have been shown to
yield more reliable results as they minimise methodo-
logical biases more than non-forced-choice testing
designs, which can be influenced by patient criterion
differences.9 The Pelli-Robson chart has also been
shown to have good test–retest reliability. Although
research has shown there was a slight increase in mean
CS scores on retest of 0.025 Log CS, this was not
considered clinically significant. In addition, the coeffi-
cient of repeatability of all the test–retest CS scores was
0.15 Log CS.9
While the Pelli-Robson chart is a suitable test for
adults, it is not suitable for use in young children, due to
the stimuli consisting of letters and the increased number
of contrast levels on the chart. At present the most
readily available clinical tests for assessing CS in
children are the LEA low contrast symbols fixed CS
charts, the LEA grating test and the Hiding Heidi CS
test.13,45 Additional tests include the Vistech system and
the Cambridge CS test.46,47 Although each test has its
individual clinical value, problems have been identified
such as the overestimation of the CS threshold in
children. This results in the levels of CS in the tests not
being sufficiently low to measure a true threshold, and
thus of limited use for children with normal or near
normal VA.13,47 For example, although the Hiding Heidi
test has demonstrated a positive correlation with the
Pelli-Robson chart, Hiding Heidi has been shown on
average to measure Log CS 0.23 units higher than the
Pelli-Robson chart and can also be subjective, resulting
in bias.13,48 Although it has not directly been compared
with the Pelli-Robson chart, the Cambridge CS test has
been shown to have low test–retest reliability; reliability
was shown to improve if the same examiner assessed the
individual, but not by a significant value.46,47 There are
currently no paediatric optotype tests of CS which are
directly comparable with the Pelli-Robson CS test.13
Table 2. Normative CS thresholds assessed with the Pelli-Robson
chart tested at 1 m
Author Age at test
(years)
Average result (Log CS)
Haragadon et al.44 6 Mean Ô SD, RE: 1.63 Ô 0.12,
LE: 1.65 Ô 0.06
O’Connor et al.33 11 Median (IQR), RE: 1.65 (1.575,
1.65), LE: 1.65 (1.60, 1.65),
BE: 1.90 (1.80, 1.95)
Leat and
Wegmann13
6 to <8 Mean (95% CI based on SD),
monocular results: 1.68 (1.57)
Leat and
Wegmann13
23 to 37 Monocular results: 1.79 (1.59)
Mantyjarvi and
Laitinen42
6 to 9 Mean Ô SD, RE: 1.72 Ô 0.08,
LE: 1.76 Ô 0.07, BE: 1.91 Ô 0.07
Mantyjarvi and
Laitinen42
10 to 19 Mean Ô SD, RE: 1.73 Ô 0.08,
LE: 1.76 Ô 0.07, BE: 1.91 Ô 0.07
RE, right eye; LE, left eye; BE, both eyes.
12 A. F. Milling et al.
Br Ir Orthopt J 2014; 11
Optimum paediatric contrast sensitivity test design
Arden stated that the failure to assess or measure CS is a
defect in our ability to diagnose and monitor its pro-
gress.2 Therefore, the development of a new paediatric
CS test which is quick, reliable and as repeatable as the
adult Pelli-Robson CS test is desirable. A picture
optotype test of a fixed spatial frequency and reducing
contrast, with 16 levels comparable to the Pelli-Robson
chart is preferable. This will ensure there is a degree of
standardisation between adult and paediatric testing.9
Having 16 contrast levels will minimise the risk of a
ceiling effect, therefore increasing the reliability. The
Pelli-Robson chart has shown good test reliability;
therefore a new paediatric test of CS would need to aim
for the same standards.9 Each contrast level on the
paediatric test would need to consist of a triplet of
optotypes which equally have a good recognition level
with children, so the child can give the answer verbally
or through matching to avoid bias. The new paediatric
test would be able to assess CS at either a 3 m or a 1 m
distance and, due to the test being the same format as the
Pelli-Robson chart, individual optotypes would be able
to be scored at a value of 0.05 Log CS.42,50 Patients
would be required to read the symbols, starting with
those of the highest contrast, until two or three optotypes
in a triplet were read incorrectly.
Conclusion
This review highlights the value of testing CS in certain
situations and conditions affecting a paediatric popula-
tion, such as prematurity, children with Down syndrome
and developmental delay, and children with ocular
conditions such as primary congenital glaucoma, optic
pathway gliomas and optic neuritis. The range of
functional deficits that accompanies paediatric ocular
disease requires assessments for full evaluation of visual
function in addition to standard VA tests. However,
reliable assessments for currently existing CS tests
suitable for paediatric use are limited. A new paediatric
CS test may be of clinical value. The test should be able
to provide an accurate measure of functional vision in
children with and without a visual impairment. Such a
test will allow clinicians to establish an individual’s
functional level of vision and aid with rehabilitative
strategies if required.
To avoid any conflict of interest the editorial decision on this paper
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